Clinical Trial Update: Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating monoclonal antibody therapy in children with metastatic neuroblastoma in second remission has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Monoclonal antibody therapy

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Neuroblastoma | Phase 2 | Status: COMPLETED